MeSH D059787 - acute pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Hisamitsu Pharmaceutical | Menthol, Methyl salicylate | Salonpas | 2027-08-01 | 2008-02-20 |  |  |
| Trevena | Oliceridine | Olinvyk | 2032-03-23 | 2020-10-30 |  |  |
| Pacira BioSciences | Bupivacaine | Exparel |  | 2020-11-16 | $545.204 M | Q4/23-Q3/24 |
Clinical Trials
Historical Success Rate
Phase 1
97%37/38
Phase 2
71%39/55
Phase 3
70%35/50
Approved: 3Overall Success rate: 48%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use